Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy
about
Systematic review of biomarkers to monitor therapeutic response in leishmaniasisDeficiency of p110δ isoform of the phosphoinositide 3 kinase leads to enhanced resistance to Leishmania donovaniInaccuracy of enzyme-linked immunosorbent assay using soluble and recombinant antigens to detect asymptomatic infection by Leishmania infantum.Immunoglobulin E antileishmanial antibody response in cutaneous leishmaniasis.Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic testPreclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.Detection of anti-leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of American visceral leishmaniasisImmune response regulation by leishmania secreted and nonsecreted antigens.Vaccine Development Against Leishmania donovani.Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
P2860
Q26866450-C2660D62-E348-42E8-AA6D-14AE8683BAA7Q28539842-FCA53FFD-53FA-4A13-A084-722E0F025B63Q33511436-F6E58E28-1E91-44DB-8B74-05E8F98673EFQ33941407-02BDD4D7-037A-40EF-B202-467B2E374591Q34149280-539D8001-96E4-4E85-8FF2-2E0EE6CC1D47Q34395015-94350DE5-BF42-4C8D-AC08-4D8F51961474Q35383603-A648B46B-F149-43F4-AC2F-021EE70B31FAQ35548955-697A3AA3-48EA-4C99-820F-2AAB28882048Q35783612-139AAE86-A070-45F7-81C6-10A88C503C90Q36915063-41FBFFB7-3741-46FD-A1A1-D9E7AF79BD35Q38012112-DCF3DF76-28BF-4909-9C2C-7FE1EC904E76Q42721940-FB1DD967-FC99-449D-803A-43809EE257E6
P2860
Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Differential decline in Leishm ...... ar patients after chemotherapy
@ast
Differential decline in Leishm ...... ar patients after chemotherapy
@en
Differential decline in Leishm ...... ar patients after chemotherapy
@nl
type
label
Differential decline in Leishm ...... ar patients after chemotherapy
@ast
Differential decline in Leishm ...... ar patients after chemotherapy
@en
Differential decline in Leishm ...... ar patients after chemotherapy
@nl
prefLabel
Differential decline in Leishm ...... ar patients after chemotherapy
@ast
Differential decline in Leishm ...... ar patients after chemotherapy
@en
Differential decline in Leishm ...... ar patients after chemotherapy
@nl
P2093
P2860
P921
P1476
Differential decline in Leishm ...... ar patients after chemotherapy
@en
P2093
D Banerjee
N Pramanik
R P Goswami
P2860
P304
P407
P577
1999-12-01T00:00:00Z